A cost-effectiveness analysis of docetaxel in the second-line treatment of non-small cell lung cancer (Q44946258)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A cost-effectiveness analysis of docetaxel in the second-line treatment of non-small cell lung cancer
scientific article

    Statements

    A cost-effectiveness analysis of docetaxel in the second-line treatment of non-small cell lung cancer (English)
    Jeremy Holmes
    David Dunlop
    Lindsay Hemmett
    Peter Sharplin
    Uday Bose
    1 January 2004
    581-589

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit